News

News
Partner news

AdoRx Therapeutics Announces Collaboration with Johnson & Johnson Innovation to Develop Novel Lung Cancer Therapeutics

Read full story
Partner news

Bavarian Nordic Announces Initiation of Phase 1/2a Clinical Trial of Therapeutic HPV Vaccine Regimen in Collaboration with Janssen

Read full story
Partner news

Calypso Biotech BV Secures 20 Million EUR in Series A Financing and Strengthens Team to Develop Anti-IL-15 Therapeutic Antibody for Autoimmune Diseases

Read full story
Partner news

Vor Biopharma Completes $42 Million Series A Financing Round to Advance Lead Cell Therapy Product Candidate for the Treatment of Acute Myeloid Leukemia

Read full story
Partner news

New strategic partners join £9.5 million dementia drug discovery collaboration

Read full story
Partner news

FACIT-Seeded Fusion Pharmaceuticals Closes US$25M Series A Led by Johnson & Johnson Innovation

Read full story
Partner news

Ethicon Announces Agreement to Acquire Torax Medical, Inc.

Read full story
Partner news

Medicxi Ventures Launches as an Independent Venture Capital Firm and Announces Closing of a €210m Fund

Read full story
Partner news

Genocea Biosciences, Inc. Announces Closing of Initial Public Offering

Read full story
Partner news

PhaseBio Launches Clinical Program to Evaluate Novel VPAC2 Agonist for Cardiovascular Disease

Read full story
Partner news

Celladon Corporation Completes $43 Million Financing to Advance MYDICAR® for the Treatment of Heart Failure

Read full story
Partner news

Five Prime Therapeutics Confirms Appointment of Lewis T. "Rusty" Williams as CEO and Announces the Appointment of Brian Atwood as Chairman of the Board

Read full story
Partner news

New Pneumococcal Vaccine Approach Successful in Early Tests – Children’s Hospital Boston and Genocea Biosciences, Inc.

Read full story
Partner news

Light Sciences Oncology Meets a Major Milestone in Aptocine Development with Target Enrollment in Phase 3 MCRC Trial

Read full story
Partner news

Five Prime Therapeutics, Inc. Announces Milestone for Therapeutic Program

Read full story